There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Adults 65 years and older (seniors) experience more complications following influenza
infection than younger adults. We estimated the relative vaccine effectiveness (rVE)
of a trivalent high dose (HD-IIV3) versus an adjuvanted trivalent influenza vaccine
(aIIV3) in seniors for respiratory-related hospitalizations.